{"id":860606,"date":"2025-06-16T03:47:13","date_gmt":"2025-06-16T07:47:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/"},"modified":"2025-06-16T03:47:13","modified_gmt":"2025-06-16T07:47:13","slug":"final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/","title":{"rendered":"FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n LOS ANGELES<\/span>
\n <\/span>, June 16, 2025<\/span><\/span> \/PRNewswire\/ — The DJS Law Group<\/a>\u00a0reminds investors of a class action lawsuit against Zenas Biopharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws.<\/p>\n

\n

\n
\n \"DJS
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Shareholders who purchased the Company’s securities pursuant and\/or traceable to the Company’s Offering Documents issued in connection with its initial public offering (“IPO”) conducted on September 13, 2024<\/span>, are encouraged to contact the firm before June 16, 2025<\/span>.<\/p>\n

\n CASE DETAILS:<\/b> The complaint alleges<\/span> that the Company made false and misleading statements to the market. Zenas allegedly<\/span> deceptively overstated the runway of funded operations it had based on existing cash and the expected net proceeds of its IPO. Based on this fact, the Company’s public statements were false and materially misleading throughout the IPO period. When the market learned the truth about Zenas, investors suffered damages.<\/p>\n

If you are a shareholder who suffered a loss,\u00a0contact us to participate<\/a>.<\/p>\n

\n WHY DJS LAW GROUP?<\/b>\u00a0DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\n CONTACT:
<\/b>
\n David J. Schwartz<\/span>
\n
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY<\/span> 10709
Phone: 914-206-9742<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/final-alert-notice—zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit—contact-the-djs-law-group-to-discuss-your-rights—zbio-302481996.html<\/a><\/p>\n

SOURCE DJS Law Group LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire LOS ANGELES , June 16, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0reminds investors of a class action lawsuit against Zenas Biopharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws. Shareholders who purchased the Company’s securities pursuant and\/or traceable to the Company’s Offering Documents issued in connection with its initial public offering (“IPO”) conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025. CASE DETAILS: The complaint alleges that the Company made false and misleading statements to the market. Zenas allegedly deceptively overstated the runway of funded operations it had based on existing cash and the expected net proceeds of its IPO. Based on this fact, the Company’s … <\/p>\n

Continue reading “FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-860606","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , June 16, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0reminds investors of a class action lawsuit against Zenas Biopharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws. Shareholders who purchased the Company’s securities pursuant and\/or traceable to the Company’s Offering Documents issued in connection with its initial public offering (“IPO”) conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025. CASE DETAILS: The complaint alleges that the Company made false and misleading statements to the market. Zenas allegedly deceptively overstated the runway of funded operations it had based on existing cash and the expected net proceeds of its IPO. Based on this fact, the Company’s … Continue reading "FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-16T07:47:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2711260\/DJS_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO\",\"datePublished\":\"2025-06-16T07:47:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/\"},\"wordCount\":303,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2711260\\\/DJS_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/\",\"name\":\"FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2711260\\\/DJS_Logo.jpg\",\"datePublished\":\"2025-06-16T07:47:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2711260\\\/DJS_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2711260\\\/DJS_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/","og_locale":"en_US","og_type":"article","og_title":"FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , June 16, 2025 \/PRNewswire\/ — The DJS Law Group\u00a0reminds investors of a class action lawsuit against Zenas Biopharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws. Shareholders who purchased the Company’s securities pursuant and\/or traceable to the Company’s Offering Documents issued in connection with its initial public offering (“IPO”) conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025. CASE DETAILS: The complaint alleges that the Company made false and misleading statements to the market. Zenas allegedly deceptively overstated the runway of funded operations it had based on existing cash and the expected net proceeds of its IPO. Based on this fact, the Company’s … Continue reading \"FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-16T07:47:13+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2711260\/DJS_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO","datePublished":"2025-06-16T07:47:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/"},"wordCount":303,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2711260\/DJS_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/","name":"FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2711260\/DJS_Logo.jpg","datePublished":"2025-06-16T07:47:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2711260\/DJS_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2711260\/DJS_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/final-alert-notice-zbio-shareholders-have-the-right-to-lead-the-zenas-biopharma-inc-securities-lawsuit-contact-the-djs-law-group-to-discuss-your-rights-zbio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FINAL ALERT NOTICE – ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit – Contact the DJS Law Group to Discuss Your Rights – ZBIO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/860606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=860606"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/860606\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=860606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=860606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=860606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}